In both oncocytic and non-oncocytic thyroid cancers, MIEAP expression is often lost, likely due to epigenetic changes (75), suggesting that it may also function as a tumor suppressor in thyroid cancer. This evidence concerns the gene SPATA18 and neoplasm.